İçeriğe geç
akaturk Akademik ölçüm
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 139
YÖKSİS139 OpenAlex0
Proje 0
Kitap 3
Bildiri 11

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 26
h-indeks 14 Türkiye yüzdelik dilimi: 93 Üniversitesinde h-indekse göre 96. / 1.484
i10-indeks
16
Toplam atıf
780
Türkiye’de üst %6,4
Makale başına
30,0
FWCI
2,19
1,00 = dünya ortalaması
Dünyada üst %1
1
Dünyada üst %10
7

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 111
  • Q1 24
  • Q2 63
  • Q3 20
  • Q4 4
WoS (JCR) 116
  • Q1 18
  • Q2 21
  • Q3 54
  • Q4 24
TR Index TR Index

11 makale

OpenAlex atıf yüzdelik
  • Üst %1 1
  • Üst %10 7
  • Ort. 73.8%
  • n 24
Diğer sayımlar

Scopus (SJR)

  • Özet hariç 110 Q1 23 Q2 63 Q3 20 Q4 4
  • YÖKSİS satırı 118

WoS (JCR)

  • Özet hariç 115 Q1 17 Q2 21 Q3 54 Q4 24
  • En iyi Q 116 Q1 18 Q2 21 Q3 54 Q4 23
  • YÖKSİS satırı 123

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

52 dergi

Makale listesi

  1. 2025 Vascular Calcification in Takayasu Arteritis; Relationship with Metabolic Syndrome, Left Ventricular Mass Index and Intima-Media Thickness Hellenic Journal of Cardiology DOI 10.1016/j.hjc.2024.04.007 YÖKSİS SJR Q2 JCR Q2
  2. 2025 A new characteristic of SLE: subclinical vein involvement–an in-depth biochemical and imaging study Rheumatology DOI 10.1093/rheumatology/keaf468 YÖKSİS SJR Q1 JCR Q1
  3. 2025 TNF ınhibitor resistance in ankylosing spondylitis: is Helicobacter pylori the overlooked culprit? Clinical Rheumatology DOI 10.1007/s10067-025-07536-3 YÖKSİS SJR Q2 JCR Q3
  4. 2025 Lupus and IgA nephropathy: coexistence or coincident? Wiener klinische Wochenschrift DOI 10.1007/s00508-025-02512-y YÖKSİS SJR Q2 JCR Q2
  5. 2025 Importance of potential prothrombotic state markers in Behçet’s disease and correlation with vascular ultrasound Irish Journal of Medical Science (1971 -) DOI 10.1007/s11845-025-03972-x YÖKSİS SJR Q2 JCR Q2 OpenAlex 17.7%
  6. 2025 POS0583 IL-40: A NOVEL PROINFLAMMATORY B CELL-ASSOCIATED CYTOKINE AND ITS ROLE IN SYSTEMIC SCLEROSIS Annals of the Rheumatic Diseases DOI 10.1016/j.ard.2025.05.965 YÖKSİS SJR Q1 JCR Q1
  7. 2025 PRDX-4: a novel biomarker similar to KL-6 for predicting the occurrence and progression of systemic sclerosis-ILD Biomarkers in Medicine DOI 10.1080/17520363.2025.2485014 YÖKSİS SJR Q2 JCR Q3
  8. 2025 Evaluation of treatment compliance in gout patients: a patient-centered study Turkish Journal of Medical Sciences DOI 10.55730/1300-0144.5985 YÖKSİS TR Index SJR Q3 JCR Q2 OpenAlex 65.4%
  9. 2025 Is Myopenia or Myosteatosis Clinically Relevant in Systemic Sclerosis? Skeletal Muscle Assessment Using Computed Tomography Academic Radiology DOI 10.1016/j.acra.2025.02.032 YÖKSİS SJR Q1 JCR Q1
  10. 2025 Serum CXCL-13 levels are associated with active neurological involvement in patients with systemic lupus erythematosus Lupus DOI 10.1177/09612033251319405 YÖKSİS SJR Q2 JCR Q3
  11. 2024 Assessment and comparison of the 2023 ACR/EULAR APS criteria with the revised Sapporo criteria International Journal of Rheumatic Diseases DOI 10.1111/1756-185X.15175 YÖKSİS SJR Q3 JCR Q3
  12. 2024 The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies Rheumatology International DOI 10.1007/s00296-024-05708-z YÖKSİS SJR Q2 JCR Q2
  13. 2024 Colchicine-intolerant familial mediterranean fever patients: A comparative study between different colchicine doses and IL-1 inhibitor monotherapy International Immunopharmacology DOI 10.1016/j.intimp.2024.111491 YÖKSİS SJR Q1 JCR Q1
  14. 2024 Performance of the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for antineutrophil cytoplasmic antibody-associated vasculitis in previously diagnosed adult patients from Türkiye archieves of rheumatology DOI 10.46497/ArchRheumatol.2024. YÖKSİS TR Index SJR Q3 JCR Q4
  15. 2024 Frequency of sarcopenia in Turkish women with systemic lupus erythematosus Lupus Science & Medicine DOI 10.1136/lupus-2024-001204 YÖKSİS SJR Q2 JCR Q3
  16. 2024 Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry Modern Rheumatology DOI 10.1093/mr/road061 2 YÖKSİS kaydı YÖKSİS SJR Q2 JCR Q3
  17. 2024 Interleukin-21 and Interleukin-23 levels in familial Mediterranean Fever before and after treatment: the role of cytokines in disease pathogenesis Scientific Reports DOI 10.1038/s41598-024-72736-x YÖKSİS SJR Q1 JCR Q1 OpenAlex 60.0%
  18. 2024 Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients Turkish Journal of Medical Sciences DOI 10.55730/1300-0144.5768 YÖKSİS TR Index SJR Q3 JCR Q3
  19. 2024 Assessing safety and efficacy of TNFi treatment in late onset ankylosing spondylitis: a TURKBIO registry study Scientific Reports DOI 10.1038/s41598-024-65180-4 YÖKSİS SJR Q1 JCR Q1
  20. 2024 Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry clinical and experimental rheumatology DOI 10.55563/clinexprheumatol/zr7s0g. YÖKSİS SJR Q2 JCR Q2 OpenAlex 76.9%

Akademisyenlere dön